Merit Medical Systems Stock EBITDA

MMSI Stock

USD 73.78 0.40 0.55%

Merit Medical Systems fundamentals help investors to digest information that contributes to Merit Medical's financial success or failures. It also enables traders to predict the movement of Merit Stock. The fundamental analysis module provides a way to measure Merit Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merit Medical stock.

		Last Reported	Projected for Next Year
	EBITDA	223.2 M	234.4 M

The Merit Medical's current EBITDA is estimated to increase to about 234.4 M.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Merit Medical Systems Company EBITDA Analysis

Merit Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Merit Medical EBITDA

223.22 M

Most of Merit Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merit Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Merit EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Merit Medical is extremely important. It helps to project a fair market value of Merit Stock properly, considering its historical fundamentals such as EBITDA. Since Merit Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Merit Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Merit Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Long Term Debt	Good Will	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Long Term Debt Total	Deferred Long Term Liab	Long Term Investments	Accumulated Depreciation	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.72	0.96	0.98	0.97	0.93	0.56	0.87	0.95	0.94	0.85	0.96	0.94	0.57	0.84	0.68	0.6	0.69	0.76	-0.92	0.01	0.87	0.74	0.76
Total Stockholder Equity	0.98		0.66	0.96	0.99	0.9	0.87	0.67	0.87	0.97	0.98	0.73	0.97	0.95	0.61	0.85	0.69	0.55	0.71	0.78	-0.96	0.04	0.83	0.64	0.8
Net Debt	0.72	0.66		0.62	0.72	0.75	0.49	0.59	0.83	0.66	0.65	0.62	0.8	0.8	0.27	0.5	0.02	0.96	0.67	0.54	-0.65	-0.01	0.49	0.27	0.22
Retained Earnings	0.96	0.96	0.62		0.94	0.92	0.93	0.52	0.74	0.95	0.89	0.82	0.92	0.92	0.43	0.78	0.73	0.49	0.56	0.64	-0.88	0.01	0.81	0.76	0.8
Net Receivables	0.98	0.99	0.72	0.94		0.9	0.84	0.7	0.89	0.96	0.98	0.73	0.98	0.96	0.62	0.84	0.63	0.62	0.74	0.78	-0.97	0.03	0.81	0.6	0.76
Total Liab	0.97	0.9	0.75	0.92	0.9		0.94	0.4	0.82	0.87	0.85	0.94	0.9	0.89	0.49	0.79	0.63	0.63	0.63	0.7	-0.84	-0.03	0.88	0.81	0.67
Total Current Assets	0.93	0.87	0.49	0.93	0.84	0.94		0.25	0.65	0.84	0.8	0.93	0.8	0.79	0.48	0.8	0.84	0.34	0.46	0.61	-0.79	-0.05	0.9	0.94	0.8
Short Term Debt	0.56	0.67	0.59	0.52	0.7	0.4	0.25		0.77	0.65	0.73	0.12	0.71	0.67	0.5	0.39	0.08	0.62	0.75	0.67	-0.67	0.36	0.33	-0.09	0.28
Intangible Assets	0.87	0.87	0.83	0.74	0.89	0.82	0.65	0.77		0.82	0.9	0.62	0.91	0.86	0.64	0.66	0.31	0.81	0.9	0.89	-0.85	0.21	0.7	0.38	0.46
Accounts Payable	0.95	0.97	0.66	0.95	0.96	0.87	0.84	0.65	0.82		0.94	0.71	0.95	0.94	0.5	0.8	0.65	0.56	0.62	0.74	-0.92	0.02	0.8	0.62	0.79
Common Stock	0.94	0.98	0.65	0.89	0.98	0.85	0.8	0.73	0.9	0.94		0.64	0.95	0.91	0.71	0.86	0.64	0.56	0.77	0.84	-0.97	0.04	0.81	0.55	0.77
Long Term Debt	0.85	0.73	0.62	0.82	0.73	0.94	0.93	0.12	0.62	0.71	0.64		0.72	0.72	0.31	0.64	0.62	0.49	0.41	0.51	-0.63	-0.04	0.81	0.91	0.57
Good Will	0.96	0.97	0.8	0.92	0.98	0.9	0.8	0.71	0.91	0.95	0.95	0.72		0.96	0.56	0.8	0.53	0.71	0.75	0.76	-0.95	0.03	0.77	0.55	0.7
Property Plant Equipment	0.94	0.95	0.8	0.92	0.96	0.89	0.79	0.67	0.86	0.94	0.91	0.72	0.96		0.45	0.8	0.52	0.69	0.66	0.67	-0.91	-0.09	0.74	0.55	0.68
Current Deferred Revenue	0.57	0.61	0.27	0.43	0.62	0.49	0.48	0.5	0.64	0.5	0.71	0.31	0.56	0.45		0.65	0.52	0.25	0.69	0.74	-0.72	0.21	0.6	0.32	0.54
Short Term Investments	0.84	0.85	0.5	0.78	0.84	0.79	0.8	0.39	0.66	0.8	0.86	0.64	0.8	0.8	0.65		0.76	0.32	0.5	0.58	-0.89	-0.41	0.82	0.65	0.86
Net Tangible Assets	0.68	0.69	0.02	0.73	0.63	0.63	0.84	0.08	0.31	0.65	0.64	0.62	0.53	0.52	0.52	0.76		-0.15	0.18	0.4	-0.67	-0.16	0.75	0.84	0.91
Long Term Debt Total	0.6	0.55	0.96	0.49	0.62	0.63	0.34	0.62	0.81	0.56	0.56	0.49	0.71	0.69	0.25	0.32	-0.15		0.72	0.54	-0.55	0.16	0.32	0.1	0.08
Deferred Long Term Liab	0.69	0.71	0.67	0.56	0.74	0.63	0.46	0.75	0.9	0.62	0.77	0.41	0.75	0.66	0.69	0.5	0.18	0.72		0.87	-0.73	0.34	0.55	0.19	0.32
Long Term Investments	0.76	0.78	0.54	0.64	0.78	0.7	0.61	0.67	0.89	0.74	0.84	0.51	0.76	0.67	0.74	0.58	0.4	0.54	0.87		-0.76	0.35	0.76	0.4	0.47
Accumulated Depreciation	-0.92	-0.96	-0.65	-0.88	-0.97	-0.84	-0.79	-0.67	-0.85	-0.92	-0.97	-0.63	-0.95	-0.91	-0.72	-0.89	-0.67	-0.55	-0.73	-0.76		0.05	-0.78	-0.55	-0.81
Short Long Term Debt	0.01	0.04	-0.01	0.01	0.03	-0.03	-0.05	0.36	0.21	0.02	0.04	-0.04	0.03	-0.09	0.21	-0.41	-0.16	0.16	0.34	0.35	0.05		-0.08	-0.12	-0.25
Net Invested Capital	0.87	0.83	0.49	0.81	0.81	0.88	0.9	0.33	0.7	0.8	0.81	0.81	0.77	0.74	0.6	0.82	0.75	0.32	0.55	0.76	-0.78	-0.08		0.81	0.69
Net Working Capital	0.74	0.64	0.27	0.76	0.6	0.81	0.94	-0.09	0.38	0.62	0.55	0.91	0.55	0.55	0.32	0.65	0.84	0.1	0.19	0.4	-0.55	-0.12	0.81		0.7
Capital Stock	0.76	0.8	0.22	0.8	0.76	0.67	0.8	0.28	0.46	0.79	0.77	0.57	0.7	0.68	0.54	0.86	0.91	0.08	0.32	0.47	-0.81	-0.25	0.69	0.7

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Merit Medical

Ebitda Over Time

Merit Ebitda

Ebitda

234.38 Million

As of now, Merit Medical's EBITDA is increasing as compared to previous years.

According to the company disclosure, Merit Medical Systems reported earnings before interest,tax, depreciation and amortization of 223.22 M. This is 74.56% lower than that of the Health Care Equipment & Supplies sector and 52.55% lower than that of the Health Care industry. The ebitda for all United States stocks is 94.27% higher than that of the company.

Merit EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merit Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merit Medical could also be used in its relative valuation, which is a method of valuing Merit Medical by comparing valuation metrics of similar companies.

Merit Medical is currently under evaluation in ebitda category among related companies.

Merit Medical Institutional Holders

Institutional Holdings refers to the ownership stake in Merit Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Merit Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Merit Medical's value.

		Shares
Loomis, Sayles & Company Lp	2023-12-31	1.1 M
Aristotle Capital Boston, Llc	2023-12-31	869.5 K
T. Rowe Price Associates, Inc.	2023-12-31	816.8 K
Amvescap Plc.	2023-12-31	801.2 K
Westwood Holdings Group Inc	2023-12-31	748.4 K
Bank Of New York Mellon Corp	2023-12-31	745.3 K
Channing Capital Management, Llc	2023-12-31	728.2 K
Greenhouse Funds Lllp	2023-09-30	719.5 K
Northern Trust Corp	2023-12-31	713.7 K
Blackrock Inc	2023-12-31	10 M
Vanguard Group Inc	2023-12-31	6.9 M

Merit Fundamentals

	Return On Equity	0.0805
	Return On Asset	0.0399
	Profit Margin	0.08 %
	Operating Margin	0.10 %
	Current Valuation	4.58 B
	Shares Outstanding	58.06 M
	Shares Owned By Insiders	2.43 %
	Shares Owned By Institutions	97.57 %
	Number Of Shares Shorted	2.06 M
	Price To Earning	956.67 X
	Price To Book	3.51 X
	Price To Sales	3.35 X
	Revenue	1.25 B
	Gross Profit	519.1 M
	EBITDA	223.22 M
	Net Income	94.41 M
	Cash And Equivalents	51.48 M
	Cash Per Share	0.91 X
	Total Debt	891.36 M
	Debt To Equity	0.26 %
	Current Ratio	2.35 X
	Book Value Per Share	20.77 X
	Cash Flow From Operations	145.15 M
	Short Ratio	5.61 X
	Earnings Per Share	1.62 X
	Price To Earnings To Growth	1.91 X
	Target Price	93.6
	Number Of Employees	6.95 K
	Beta	0.91
	Market Capitalization	4.28 B
	Total Asset	2.33 B
	Retained Earnings	575.18 M
	Working Capital	904.91 M
	Current Asset	204 M
	Current Liabilities	87.91 M
	Net Asset	2.33 B

About Merit Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Merit Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merit Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merit Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:

How To Invest In Merit

Details

Is Merit Stock a good investment?

Details

What is Merit Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Merit Medical Piotroski F Score and Merit Medical Altman Z Score analysis.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Merit Stock analysis

When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.

	Global Correlations Find global opportunities by holding instruments from different markets
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Stocks Directory Find actively traded stocks across global markets
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Money Managers Screen money managers from public funds and ETFs managed around the world
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments

Is Merit Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.17)

Earnings Share

1.62

Revenue Per Share

21.832

Quarterly Revenue Growth

0.106

Return On Assets

0.0399

The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Merit Medical Systems Stock EBITDA

Merit Medical Systems Company EBITDA Analysis

EBITDA

Revenue

-

Basic Expenses

Current Merit Medical EBITDA

Merit EBITDA Driver Correlations

Merit Ebitda

Ebitda

234.38 Million

Merit EBITDA Peer Comparison

Merit Medical Institutional Holders

Merit Fundamentals

About Merit Medical Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Merit Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY